SGLT2 inhibitor activates the STING/IRF3/IFN-β pathway and induces immune infiltration in osteosarcoma

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2041-4889

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: SGLT2 inhibitor activates the STING/IRF3/IFN-β pathway and induces immune infiltration in osteosarcoma ; volume:13 ; number:6 ; day:3 ; month:6 ; year:2022 ; pages:1-13 ; date:6.2022
Cell death & disease ; 13, Heft 6 (3.6.2022), 1-13, 6.2022

Creator: Wu, Wei
Zhang, Zhenhao
Jing, Doudou
Huang, Xin
Ren, Dianyun
Shao, Zengwu
Zhang, Zhicai

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41419-022-04980-w

URN: urn:nbn:de:101:1-2022080222573376020309

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:29 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Wu, Wei
Zhang, Zhenhao
Jing, Doudou
Huang, Xin
Ren, Dianyun
Shao, Zengwu
Zhang, Zhicai
SpringerLink (Online service)

Other Objects (12)

Interruption of post-Golgi STING trafficking activates tonic interferon signaling

DUSP4 modulates RIG-I- and STING-mediated IRF3-type I IFN response

TLR9 and STING agonists synergistically induce innate and adaptive type‐II IFN

CircECE1 activates energy metabolism in osteosarcoma by stabilizing c-Myc

A bioactive mammalian disaccharide associated with autoimmunity activates STING-TBK1-dependent immune response

ARF1 controls STING activation and recycling to prevent chronic type I IFN signalling

PRV UL13 inhibits cGAS–STING-mediated IFN-β production by phosphorylating IRF3

A Manganese Phosphate Nanocluster Activates the cGAS‐STING Pathway for Enhanced Cancer Immunotherapy

Cellular stress signaling activates type-I IFN response through FOXO3-regulated lamin posttranslational modification

Knockdown of CENPM activates cGAS-STING pathway to inhibit ovarian cancer by promoting pyroptosis

Bifunctional Metal–Organic Framework Synergistically Enhances Radiotherapy and Activates STING for Potent Cancer Radio‐Immunotherapy

Interruption of post-Golgi STING trafficking activates tonic interferon signaling

DUSP4 modulates RIG-I- and STING-mediated IRF3-type I IFN response

TLR9 and STING agonists synergistically induce innate and adaptive type‐II IFN

CircECE1 activates energy metabolism in osteosarcoma by stabilizing c-Myc

A bioactive mammalian disaccharide associated with autoimmunity activates STING-TBK1-dependent immune response

ARF1 controls STING activation and recycling to prevent chronic type I IFN signalling

PRV UL13 inhibits cGAS–STING-mediated IFN-β production by phosphorylating IRF3

A Manganese Phosphate Nanocluster Activates the cGAS‐STING Pathway for Enhanced Cancer Immunotherapy

Cellular stress signaling activates type-I IFN response through FOXO3-regulated lamin posttranslational modification

Knockdown of CENPM activates cGAS-STING pathway to inhibit ovarian cancer by promoting pyroptosis

Bifunctional Metal–Organic Framework Synergistically Enhances Radiotherapy and Activates STING for Potent Cancer Radio‐Immunotherapy

Interruption of post-Golgi STING trafficking activates tonic interferon signaling

DUSP4 modulates RIG-I- and STING-mediated IRF3-type I IFN response

TLR9 and STING agonists synergistically induce innate and adaptive type‐II IFN

CircECE1 activates energy metabolism in osteosarcoma by stabilizing c-Myc

A bioactive mammalian disaccharide associated with autoimmunity activates STING-TBK1-dependent immune response

ARF1 controls STING activation and recycling to prevent chronic type I IFN signalling

PRV UL13 inhibits cGAS–STING-mediated IFN-β production by phosphorylating IRF3

A Manganese Phosphate Nanocluster Activates the cGAS‐STING Pathway for Enhanced Cancer Immunotherapy

Cellular stress signaling activates type-I IFN response through FOXO3-regulated lamin posttranslational modification

Knockdown of CENPM activates cGAS-STING pathway to inhibit ovarian cancer by promoting pyroptosis

Bifunctional Metal–Organic Framework Synergistically Enhances Radiotherapy and Activates STING for Potent Cancer Radio‐Immunotherapy

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

SGLT2 inhibitor activates the STING/IRF3/IFN-β pathway and induces immune infiltration in osteosarcoma

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Interruption of post-Golgi STING trafficking activates tonic interferon signaling

DUSP4 modulates RIG-I- and STING-mediated IRF3-type I IFN response

TLR9 and STING agonists synergistically induce innate and adaptive type‐II IFN

CircECE1 activates energy metabolism in osteosarcoma by stabilizing c-Myc

A bioactive mammalian disaccharide associated with autoimmunity activates STING-TBK1-dependent immune response

ARF1 controls STING activation and recycling to prevent chronic type I IFN signalling

PRV UL13 inhibits cGAS–STING-mediated IFN-β production by phosphorylating IRF3

A Manganese Phosphate Nanocluster Activates the cGAS‐STING Pathway for Enhanced Cancer Immunotherapy

Cellular stress signaling activates type-I IFN response through FOXO3-regulated lamin posttranslational modification

Knockdown of CENPM activates cGAS-STING pathway to inhibit ovarian cancer by promoting pyroptosis

Bifunctional Metal–Organic Framework Synergistically Enhances Radiotherapy and Activates STING for Potent Cancer Radio‐Immunotherapy

Bifunctional Metal–Organic Framework Synergistically Enhances Radiotherapy and Activates STING for Potent Cancer Radio‐Immunotherapy

Interruption of post-Golgi STING trafficking activates tonic interferon signaling

DUSP4 modulates RIG-I- and STING-mediated IRF3-type I IFN response

TLR9 and STING agonists synergistically induce innate and adaptive type‐II IFN

CircECE1 activates energy metabolism in osteosarcoma by stabilizing c-Myc

A bioactive mammalian disaccharide associated with autoimmunity activates STING-TBK1-dependent immune response

ARF1 controls STING activation and recycling to prevent chronic type I IFN signalling

PRV UL13 inhibits cGAS–STING-mediated IFN-β production by phosphorylating IRF3

A Manganese Phosphate Nanocluster Activates the cGAS‐STING Pathway for Enhanced Cancer Immunotherapy

Cellular stress signaling activates type-I IFN response through FOXO3-regulated lamin posttranslational modification

Knockdown of CENPM activates cGAS-STING pathway to inhibit ovarian cancer by promoting pyroptosis

Bifunctional Metal–Organic Framework Synergistically Enhances Radiotherapy and Activates STING for Potent Cancer Radio‐Immunotherapy

Bifunctional Metal–Organic Framework Synergistically Enhances Radiotherapy and Activates STING for Potent Cancer Radio‐Immunotherapy

Interruption of post-Golgi STING trafficking activates tonic interferon signaling

DUSP4 modulates RIG-I- and STING-mediated IRF3-type I IFN response

TLR9 and STING agonists synergistically induce innate and adaptive type‐II IFN

CircECE1 activates energy metabolism in osteosarcoma by stabilizing c-Myc

A bioactive mammalian disaccharide associated with autoimmunity activates STING-TBK1-dependent immune response

ARF1 controls STING activation and recycling to prevent chronic type I IFN signalling

PRV UL13 inhibits cGAS–STING-mediated IFN-β production by phosphorylating IRF3

A Manganese Phosphate Nanocluster Activates the cGAS‐STING Pathway for Enhanced Cancer Immunotherapy

Cellular stress signaling activates type-I IFN response through FOXO3-regulated lamin posttranslational modification

Knockdown of CENPM activates cGAS-STING pathway to inhibit ovarian cancer by promoting pyroptosis

Bifunctional Metal–Organic Framework Synergistically Enhances Radiotherapy and Activates STING for Potent Cancer Radio‐Immunotherapy

Bifunctional Metal–Organic Framework Synergistically Enhances Radiotherapy and Activates STING for Potent Cancer Radio‐Immunotherapy

Related objects

Reset password